Finance

Lists
Why is INBX down 3,25%?
Dive Deeper
INBX:NASDAQ
Inhibrx Biosciences Inc
91,92 $
-3,25%
(-3,09) 1D
12 հոկ, 14:14:51 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INBX...
Open
94,03 $
High
96,10 $
Low
91,23 $
Mkt. cap
1,35 մլրդ
Avg. vol.
312,44 հզր
Volume
56,05 հզր
52-wk high
155,29 $
52-wk low
28,16 $
EPS
-8,88 $
Shares outstanding
14,72 մլն
No. of employees
110
Open
94,03 $
High
96,10 $
Low
91,23 $
Mkt. cap
1,35 մլրդ
Avg. vol.
312,44 հզր
Volume
56,05 հզր
52-wk high
155,29 $
52-wk low
28,16 $
EPS
-8,88 $
Shares outstanding
14,72 մլն
No. of employees
110
News stories
From web sources and news partners
About Inhibrx Biosciences Inc
CEO-
Employees110
Founded2024
HeadquartersLa Jolla, Կալիֆոռնիա, Միացյալ Նահանգներ
Sector-
Websiteinhibrx.com
Analyst ratings
Based on 3 analysts giving stock ratings to INBX in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for INBX in the last 3 months.
Highest
Current 91,92 $
325,00 $ (+253,57%)
Average
266,67 $ (+190,11%)
Lowest
230,00 $ (+150,22%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert Burns
H.C. Wainwright
Buy
Reiterated
245,00 $
+166,5%
09/09/2026
Oliver McCammon
LifeSci Capital
Buy
Maintained
230,00 $
+150,2%
09/08/2026
Dara Azar
Stifel Nicolaus
Buy
Maintained
325,00 $
+253,6%
08/21/2026
Unknown Analyst
Stifel Nicolaus
Buy
Initiated
150,00 $
+63,2%
04/08/2026
Last report
13 օգս, 2026 թ.
Fiscal period
Q2 2026
-2,34 $ / -2,28 $
-2,63%miss
Revenue / Est. (USD)
- / 0,00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
28,54 մլն
25,35 մլն
25,22 մլն
23,90 մլն
Cost of revenue
28,54 մլն
25,35 մլն
25,22 մլն
23,90 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,28 մլն
5,57 մլն
5,71 մլն
8,25 մլն
Operating expense
5,28 մլն
5,57 մլն
5,71 մլն
8,25 մլն
Total operating expenses
33,81 մլն
30,92 մլն
30,93 մլն
32,15 մլն
Operating income
-33,81 մլն
-30,92 մլն
-30,93 մլն
-32,15 մլն
Other non operating income
-46,00 հզր
-39,00 հզր
-12,00 հզր
-68,00 հզր
EBT including unusual items
-35,26 մլն
-32,83 մլն
-33,44 մլն
-36,65 մլն
EBT excluding unusual items
-35,26 մլն
-32,83 մլն
-33,44 մլն
-36,65 մլն
Income tax expense
-
-
-
3,00 հզր
Effective tax rate
-
-
-
-0,01%
Other operating expenses
-
-
-
-
Net income
-35,26 մլն
-32,83 մլն
-33,44 մլն
-36,65 մլն
Net profit margin
-
-
-
-
Earnings per share
-2,28
-2,11
-2,15
-2,34
Interest and investment income
1,78 մլն
1,31 մլն
1,01 մլն
1,26 մլն
Interest expense
-3,18 մլն
-3,18 մլն
-3,51 մլն
-5,69 մլն
Net interest expenses
-1,40 մլն
-1,87 մլն
-2,50 մլն
-4,43 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-33,23 մլն
-30,36 մլն
-30,39 մլն
-31,63 մլն
Gain or loss from assets sale
3,00 հզր
9,00 հզր
-
14,00 հզր
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps